-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 28 Nov 2025 14:32 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Notice of Extraordinary General Assembly | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 14:31 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Nov 2025 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Third Quarter Report 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Nov 2025 08:35 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured – Key Milestone for CF and EDF Clinical Programs | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Oct 2025 12:26 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund (EDF) Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Oct 2025 08:11 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Oct 2025 21:17 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placement resolved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Oct 2025 15:23 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Oct 2025 14:35 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a – Important Milestone Achieved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2025 17:51 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Clarification on Placement Commission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2025 15:08 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placements resolved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2025 09:07 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Sep 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Sep 2025 15:59 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Sep 2025 12:07 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Presentation Deck and link to today's Investor Update | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Sep 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Sep 2025 12:39 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment | 20103010 Biotechnology | Non-regulatory press releases |
| 02 Sep 2025 08:59 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Disease Treatments | 20103010 Biotechnology | Inside information |
| 26 Aug 2025 14:35 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Primary Insider Notification | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 18 Aug 2025 10:36 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Aug 2025 22:02 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placement resolved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Aug 2025 16:28 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Softox Solutions secures committed financing facility | 20103010 Biotechnology | Inside information |
| 27 Jun 2025 14:51 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board member | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jun 2025 11:08 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Minutes from the General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jun 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: First Quarter Report 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Jun 2025 08:02 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Notice of Annual General Assembly | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Jun 2025 15:08 CEST |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Board Member Resignations | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 May 2025 08:00 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 23 May 2025 14:07 CEST |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Apr 2025 15:30 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Mar 2025 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Fourth Quarter Report 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Mar 2025 10:16 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Private Placement resolved | 20103010 Biotechnology | Inside information |
| 24 Mar 2025 09:23 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Contemplated Private Placement | 20103010 Biotechnology | Inside information |
| 27 Feb 2025 22:52 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Settlement of legal dispute | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Feb 2025 12:33 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Settlement of legal dispute | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Feb 2025 12:36 CET |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Feb 2025 12:06 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: In-kind Dividend – SoftOx Wound & Skin Care AS | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Jan 2025 10:52 CET |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Dec 2024 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Ex dividend in-kind today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Dec 2024 10:48 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Minutes from the ExtraOrdinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Dec 2024 12:13 CET |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2024 09:00 CET |
SOFTOX SOLUTIONS | SoftOx Solution AS: Mandatory notification of trade by primary insiders and close associates | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Dec 2024 12:27 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Key information relating to in-kind dividend to be paid by SoftOx Solutions AS | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Dec 2024 09:00 CET |
SOFTOX SOLUTIONS | SoftOx Solution AS: Board recommendation to distribute the SoftOx Wound & Skin Care AS shares as dividend-in-kind and notice of Extraordinary General Meeting | 20103010 Biotechnology | Inside information |
| 27 Nov 2024 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solution AS: Third Quarter Report 2024 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 20 Sep 2024 08:33 CEST |
SOFTOX SOLUTIONS | SoftOx Solution AS: Mandatory notification of trade by primary insiders and close associates | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Sep 2024 10:35 CEST |
SOFTOX SOLUTIONS | SoftOx Solution AS: Leadership SoftOx Solution AS | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Sep 2024 09:59 CEST |
SOFTOX SOLUTIONS | SoftOx Solution AS: New Share Capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |